Megsan Diagnostics: Megsan and Tentamus Group begin new Indian project within the human diagnostics market (including COVID-19 testing)

“Megsan Diagnostics” stands as a joint-venture between Tentamus Group, the global product and safety group, and the team of Megsan, which share their expertise in the field of laboratories and diagnostics. Through this collaboration, Megsan Diagnosatics started its operations during the year of 2020 with its newly built state of the art laboratory.

“We have had a long-term partnership with the team of Megsan and are now delighted to continue this in starting the second project together. After entering into Megsan Labs during mid 2019, a company focused primarily on pharmaceutical testing services, this new joint venture will serve as the first service provider for human diagnostics in the Indian market. For Tentamus, this is the next logical step in the Indian market. This will be the first human diagnostics laboratory in the group and as a result, it will significantly contribute to the continuous growth in our range of expertise. In addition to this, we strive to make our contribution regarding healthcare protection within the Indian population, especially during the current time by providing the service of COVID-19 testing.”, says Abgar Barseyten, CEO Tentamus Group.

Jayapalreddy Madireddy, CEO of Megsan Diagnostics emphasizes: “we are happy to announce that we have started this joint-venture project with Tentamus Group. With Tentamus, we share our entrepreneurial spirit – that’s what makes them a perfect partner for us. This is an exceptional opportunity for Megsan and Tentamus to utilize their synergies to grow their expertise”

About Megsan Diagnostics

Megsan Diagnostics is an Indian human diagnostics laboratory and end-to-end service provider,

located in a 25,000 sqft space in Hyderabad. Megsan offers a wide spectrum of diagnostic tests, corporate check-ups, healthcare packages with uncompromising quality standards with faster TAT – all under one roof. Along with the provision for home blood sampling and quality diagnostic services through fully automated diagnostic equipment.

Megsan has recently established 16 state-of-the-art walk-in outlets for diagnostics, pharmacies and clinics, and a network of nearly 400 B2B collection points for laboratory tests.

Megsan Labs is an ICMR-approved laboratory for COVID-19 testing, providing complete COVID-19 solutions such as home swab collection, home care treatment, negative and positive health packages, immunity booster pharmacy kits using India’s first AI-driven 360-degree digital health platform.

Further information and detailed testing services can be found at www.megsandiagnostics.com

 

Über die Tentamus Group GmbH

Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan, India and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrosciences, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 65 locations worldwide. More than 2,500 highly-trained staff members work in over 2.5 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.

Firmenkontakt und Herausgeber der Meldung:

Tentamus Group GmbH
An der Industriebahn 5
13088 Berlin
Telefon: +49 (30) 206038-230
Telefax: +49 (30) 206038-190
http://tentamus.com

Ansprechpartner:
M. Jaipal Reddy
Megsan Diagnostics Pvt Ltd
Telefon: +91 (0) 90522 22154
E-Mail: jaipal@megsanlabs.com
Keerthi V. Reddy Vemula
CEO Tentamus India
E-Mail: keerthi.vemula@tentamus.com
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel